Schaeffer's Street Stories: Call Volume Swarms Genentech, Inc. as the Shares Battle Resistance

Genentech, Inc. (NYSE: DNA) has collected a respectable gain of 15% during the past 52 weeks, and the shares have bounced more than 20% higher from their Dec. 2 low near the 71 level. The equity's latest upswing has been underscored by support from its 10-day and 50-day moving averages, although resistance in the 88 region continues to stifle the shares' progress.

The stock extended its gains last week, when DNA's board rejected a hostile takeover bid from major stakeholder Roche Holding AG. As investors placed their bets on a sweetened buyout offer from Roche, call volume accelerated on the shares of Genentech.

To continue reading this article, click here:


Schaeffer's Investment Research
Elizabeth Harrow, 513-589-3800
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here